Malone just posted a link to this study on Ivermectin: "

Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors

https://openheart.bmj.com/content/8/1/e0....

Quote:

Glycine preadministration also blunts the lung injury induced by inhalation of aerosolised LPS in mice; this effect is associated with inhibition of NLR family pyrin domain containing 3 (NLRP3) inflammasome activation (thought to play a key role in COVID-19 lung inflammation17 and production of proinflammatory cytokines).18

Quote:

It is therefore suggested that the clinical utility of ivermectin in the cytokine storm phase of COVID-19 reflects, at least in part, an anti-inflammatory effect mediated by increased activation of glycine receptors on leukocytes and possibly vascular endothelium. An evident corollary of this is that ingestion of high-dose glycine may provide somewhat analogous anti-inflammatory protection in COVID-19, as has previously been suggested.

If anyone saw my earlier posts on NLRP3, think about what else suppresses this inflammation. h/t @Lizardqueen https://www.jimmunol.org/content/200/8/2....

Something to add to your anti-covid brew... (as long as you talk to your doctor yada yada)